According to new survey, global Myasthenia Gravis market is projected to reach US$ 1955.9 million in 2029, increasing from US$ 1185 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029.

Myasthenia Gravis Market

Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles (the muscles that connect to your bones and contract to allow body movement in the arms and legs, and allow for breathing).

Key companies engaged in the Myasthenia Gravis industry include Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca and Avadel Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Myasthenia Gravis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Myasthenia Gravis market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Myasthenia Gravis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Myasthenia Gravis Market Report

Report Metric	Details
Report Name	Myasthenia Gravis Market
Accounted market size in 2022	US$ 1185 million
Forecasted market size in 2029	US$ 1955.9 million
CAGR	6.4%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Monoclonal Antibodies Intravenous Immunoglobulin Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca, Avadel Pharmaceuticals, Octapharma, Astellas Pharma, Zydus Lifesciences, Kedrion S.p.A.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Myasthenia Gravis Market growing?

Ans: The Myasthenia Gravis Market witnessing a CAGR of 6.4% during the forecast period 2023-2029.

What is the Myasthenia Gravis Market size in 2029?

Ans: The Myasthenia Gravis Market size in 2029 will be US$ 1955.9 million.

Who are the main players in the Myasthenia Gravis Market report?

Ans: The main players in the Myasthenia Gravis Market are Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca, Avadel Pharmaceuticals, Octapharma, Astellas Pharma, Zydus Lifesciences, Kedrion S.p.A.

What are the Application segmentation covered in the Myasthenia Gravis Market report?

Ans: The Applications covered in the Myasthenia Gravis Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Myasthenia Gravis Market report?

Ans: The Types covered in the Myasthenia Gravis Market report are Monoclonal Antibodies, Intravenous Immunoglobulin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Monoclonal Antibodies

1.2.3 Intravenous Immunoglobulin

1.2.4 Others

1.3 Market by Application

1.3.1 Global Myasthenia Gravis Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Myasthenia Gravis Market Perspective (2018-2029)

2.2 Myasthenia Gravis Growth Trends by Region

2.2.1 Global Myasthenia Gravis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Myasthenia Gravis Historic Market Size by Region (2018-2023)

2.2.3 Myasthenia Gravis Forecasted Market Size by Region (2024-2029)

2.3 Myasthenia Gravis Market Dynamics

2.3.1 Myasthenia Gravis Industry Trends

2.3.2 Myasthenia Gravis Market Drivers

2.3.3 Myasthenia Gravis Market Challenges

2.3.4 Myasthenia Gravis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Myasthenia Gravis Players by Revenue

3.1.1 Global Top Myasthenia Gravis Players by Revenue (2018-2023)

3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2018-2023)

3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Myasthenia Gravis Revenue

3.4 Global Myasthenia Gravis Market Concentration Ratio

3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2022

3.5 Myasthenia Gravis Key Players Head office and Area Served

3.6 Key Players Myasthenia Gravis Product Solution and Service

3.7 Date of Enter into Myasthenia Gravis Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Myasthenia Gravis Breakdown Data by Type

4.1 Global Myasthenia Gravis Historic Market Size by Type (2018-2023)

4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2024-2029)

5 Myasthenia Gravis Breakdown Data by Application

5.1 Global Myasthenia Gravis Historic Market Size by Application (2018-2023)

5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Myasthenia Gravis Market Size (2018-2029)

6.2 North America Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Myasthenia Gravis Market Size by Country (2018-2023)

6.4 North America Myasthenia Gravis Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Myasthenia Gravis Market Size (2018-2029)

7.2 Europe Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Myasthenia Gravis Market Size by Country (2018-2023)

7.4 Europe Myasthenia Gravis Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Myasthenia Gravis Market Size (2018-2029)

8.2 Asia-Pacific Myasthenia Gravis Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Myasthenia Gravis Market Size by Region (2018-2023)

8.4 Asia-Pacific Myasthenia Gravis Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Myasthenia Gravis Market Size (2018-2029)

9.2 Latin America Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Myasthenia Gravis Market Size by Country (2018-2023)

9.4 Latin America Myasthenia Gravis Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Myasthenia Gravis Market Size (2018-2029)

10.2 Middle East & Africa Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Myasthenia Gravis Market Size by Country (2018-2023)

10.4 Middle East & Africa Myasthenia Gravis Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Detail

11.1.2 Takeda Business Overview

11.1.3 Takeda Myasthenia Gravis Introduction

11.1.4 Takeda Revenue in Myasthenia Gravis Business (2018-2023)

11.1.5 Takeda Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Myasthenia Gravis Introduction

11.2.4 Roche Revenue in Myasthenia Gravis Business (2018-2023)

11.2.5 Roche Recent Development

11.3 CSL Limited

11.3.1 CSL Limited Company Detail

11.3.2 CSL Limited Business Overview

11.3.3 CSL Limited Myasthenia Gravis Introduction

11.3.4 CSL Limited Revenue in Myasthenia Gravis Business (2018-2023)

11.3.5 CSL Limited Recent Development

11.4 Baxter International

11.4.1 Baxter International Company Detail

11.4.2 Baxter International Business Overview

11.4.3 Baxter International Myasthenia Gravis Introduction

11.4.4 Baxter International Revenue in Myasthenia Gravis Business (2018-2023)

11.4.5 Baxter International Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Myasthenia Gravis Introduction

11.5.4 Novartis Revenue in Myasthenia Gravis Business (2018-2023)

11.5.5 Novartis Recent Development

11.6 Bausch Health

11.6.1 Bausch Health Company Detail

11.6.2 Bausch Health Business Overview

11.6.3 Bausch Health Myasthenia Gravis Introduction

11.6.4 Bausch Health Revenue in Myasthenia Gravis Business (2018-2023)

11.6.5 Bausch Health Recent Development

11.7 Grifols

11.7.1 Grifols Company Detail

11.7.2 Grifols Business Overview

11.7.3 Grifols Myasthenia Gravis Introduction

11.7.4 Grifols Revenue in Myasthenia Gravis Business (2018-2023)

11.7.5 Grifols Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Myasthenia Gravis Introduction

11.8.4 AstraZeneca Revenue in Myasthenia Gravis Business (2018-2023)

11.8.5 AstraZeneca Recent Development

11.9 Avadel Pharmaceuticals

11.9.1 Avadel Pharmaceuticals Company Detail

11.9.2 Avadel Pharmaceuticals Business Overview

11.9.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction

11.9.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023)

11.9.5 Avadel Pharmaceuticals Recent Development

11.10 Octapharma

11.10.1 Octapharma Company Detail

11.10.2 Octapharma Business Overview

11.10.3 Octapharma Myasthenia Gravis Introduction

11.10.4 Octapharma Revenue in Myasthenia Gravis Business (2018-2023)

11.10.5 Octapharma Recent Development

11.11 Astellas Pharma

11.11.1 Astellas Pharma Company Detail

11.11.2 Astellas Pharma Business Overview

11.11.3 Astellas Pharma Myasthenia Gravis Introduction

11.11.4 Astellas Pharma Revenue in Myasthenia Gravis Business (2018-2023)

11.11.5 Astellas Pharma Recent Development

11.12 Zydus Lifesciences

11.12.1 Zydus Lifesciences Company Detail

11.12.2 Zydus Lifesciences Business Overview

11.12.3 Zydus Lifesciences Myasthenia Gravis Introduction

11.12.4 Zydus Lifesciences Revenue in Myasthenia Gravis Business (2018-2023)

11.12.5 Zydus Lifesciences Recent Development

11.13 Kedrion S.p.A.

11.13.1 Kedrion S.p.A. Company Detail

11.13.2 Kedrion S.p.A. Business Overview

11.13.3 Kedrion S.p.A. Myasthenia Gravis Introduction

11.13.4 Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2018-2023)

11.13.5 Kedrion S.p.A. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Takeda

Avadel Pharmaceuticals

List of Tables

Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Intravenous Immunoglobulin

Table 4. Key Players of Others

Table 5. Global Myasthenia Gravis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Myasthenia Gravis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)

Table 8. Global Myasthenia Gravis Market Share by Region (2018-2023)

Table 9. Global Myasthenia Gravis Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 10. Global Myasthenia Gravis Market Share by Region (2024-2029)

Table 11. Myasthenia Gravis Market Trends

Table 12. Myasthenia Gravis Market Drivers

Table 13. Myasthenia Gravis Market Challenges

Table 14. Myasthenia Gravis Market Restraints

Table 15. Global Myasthenia Gravis Revenue by Players (2018-2023) & (US$ Million)

Table 16. Global Myasthenia Gravis Market Share by Players (2018-2023)

Table 17. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)

Table 18. Ranking of Global Top Myasthenia Gravis Companies by Revenue (US$ Million) in 2022

Table 19. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2018-2023)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Myasthenia Gravis Product Solution and Service

Table 22. Date of Enter into Myasthenia Gravis Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)

Table 25. Global Myasthenia Gravis Revenue Market Share by Type (2018-2023)

Table 26. Global Myasthenia Gravis Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 27. Global Myasthenia Gravis Revenue Market Share by Type (2024-2029)

Table 28. Global Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)

Table 29. Global Myasthenia Gravis Revenue Market Share by Application (2018-2023)

Table 30. Global Myasthenia Gravis Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 31. Global Myasthenia Gravis Revenue Market Share by Application (2024-2029)

Table 32. North America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. North America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)

Table 34. North America Myasthenia Gravis Market Size by Country (2024-2029) & (US$ Million)

Table 35. Europe Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. Europe Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)

Table 37. Europe Myasthenia Gravis Market Size by Country (2024-2029) & (US$ Million)

Table 38. Asia-Pacific Myasthenia Gravis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 39. Asia-Pacific Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)

Table 40. Asia-Pacific Myasthenia Gravis Market Size by Region (2024-2029) & (US$ Million)

Table 41. Latin America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 42. Latin America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)

Table 43. Latin America Myasthenia Gravis Market Size by Country (2024-2029) & (US$ Million)

Table 44. Middle East & Africa Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 45. Middle East & Africa Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)

Table 46. Middle East & Africa Myasthenia Gravis Market Size by Country (2024-2029) & (US$ Million)

Table 47. Takeda Company Detail

Table 48. Takeda Business Overview

Table 49. Takeda Myasthenia Gravis Product

Table 50. Takeda Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 51. Takeda Recent Development

Table 52. Roche Company Detail

Table 53. Roche Business Overview

Table 54. Roche Myasthenia Gravis Product

Table 55. Roche Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 56. Roche Recent Development

Table 57. CSL Limited Company Detail

Table 58. CSL Limited Business Overview

Table 59. CSL Limited Myasthenia Gravis Product

Table 60. CSL Limited Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 61. CSL Limited Recent Development

Table 62. Baxter International Company Detail

Table 63. Baxter International Business Overview

Table 64. Baxter International Myasthenia Gravis Product

Table 65. Baxter International Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 66. Baxter International Recent Development

Table 67. Novartis Company Detail

Table 68. Novartis Business Overview

Table 69. Novartis Myasthenia Gravis Product

Table 70. Novartis Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 71. Novartis Recent Development

Table 72. Bausch Health Company Detail

Table 73. Bausch Health Business Overview

Table 74. Bausch Health Myasthenia Gravis Product

Table 75. Bausch Health Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 76. Bausch Health Recent Development

Table 77. Grifols Company Detail

Table 78. Grifols Business Overview

Table 79. Grifols Myasthenia Gravis Product

Table 80. Grifols Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 81. Grifols Recent Development

Table 82. AstraZeneca Company Detail

Table 83. AstraZeneca Business Overview

Table 84. AstraZeneca Myasthenia Gravis Product

Table 85. AstraZeneca Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 86. AstraZeneca Recent Development

Table 87. Avadel Pharmaceuticals Company Detail

Table 88. Avadel Pharmaceuticals Business Overview

Table 89. Avadel Pharmaceuticals Myasthenia Gravis Product

Table 90. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 91. Avadel Pharmaceuticals Recent Development

Table 92. Octapharma Company Detail

Table 93. Octapharma Business Overview

Table 94. Octapharma Myasthenia Gravis Product

Table 95. Octapharma Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 96. Octapharma Recent Development

Table 97. Astellas Pharma Company Detail

Table 98. Astellas Pharma Business Overview

Table 99. Astellas Pharma Myasthenia Gravis Product

Table 100. Astellas Pharma Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 101. Astellas Pharma Recent Development

Table 102. Zydus Lifesciences Company Detail

Table 103. Zydus Lifesciences Business Overview

Table 104. Zydus Lifesciences Myasthenia Gravis Product

Table 105. Zydus Lifesciences Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 106. Zydus Lifesciences Recent Development

Table 107. Kedrion S.p.A. Company Detail

Table 108. Kedrion S.p.A. Business Overview

Table 109. Kedrion S.p.A. Myasthenia Gravis Product

Table 110. Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 111. Kedrion S.p.A. Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Myasthenia Gravis Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Myasthenia Gravis Market Share by Type: 2022 VS 2029

Figure 3. Monoclonal Antibodies Features

Figure 4. Intravenous Immunoglobulin Features

Figure 5. Others Features

Figure 6. Global Myasthenia Gravis Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 7. Global Myasthenia Gravis Market Share by Application: 2022 VS 2029

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Myasthenia Gravis Report Years Considered

Figure 12. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 13. Global Myasthenia Gravis Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Myasthenia Gravis Market Share by Region: 2022 VS 2029

Figure 15. Global Myasthenia Gravis Market Share by Players in 2022

Figure 16. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)

Figure 17. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2022

Figure 18. North America Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 19. North America Myasthenia Gravis Market Share by Country (2018-2029)

Figure 20. United States Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. Canada Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Europe Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Myasthenia Gravis Market Share by Country (2018-2029)

Figure 24. Germany Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. France Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. U.K. Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Italy Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Russia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Nordic Countries Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Asia-Pacific Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Asia-Pacific Myasthenia Gravis Market Share by Region (2018-2029)

Figure 32. China Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Japan Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. South Korea Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. India Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Australia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Latin America Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Latin America Myasthenia Gravis Market Share by Country (2018-2029)

Figure 40. Mexico Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Brazil Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Middle East & Africa Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Middle East & Africa Myasthenia Gravis Market Share by Country (2018-2029)

Figure 44. Turkey Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 47. Roche Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 48. CSL Limited Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 49. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 50. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 51. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 52. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 53. AstraZeneca Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 54. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 55. Octapharma Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 56. Astellas Pharma Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 57. Zydus Lifesciences Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 58. Kedrion S.p.A. Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions